Draganfly inc. to begin delivering nugen medical device's needle-free injection devices and insulin to ukraine type 1 diabetics in urgent need of supply

Revived soldiers ukraine deploy draganfly's medical response drones to deliver nugen m.d.'s needle-free injection devices, coupled with insulin, to conflict areas across ukraine toronto, on / accesswire / may 12, 2022 / nugen medical devices inc. (tsxv:ngmd) ("nugen'' or the "company"), a leader in needle-free drug delivery, is pleased to announce that the company has selected draganfly inc. (nasdaq: dpro) (cse: dpro) (fse: 3u8) ("draganfly"), an award-winning, industry-leading drone solutions and systems developer, and coldchain delivery systems, inc. ("coldchain delivery systems") to provide drones and services for the delivery of nugen's needle-free injection system, known as insujet™, insulin, and other crucial medical supplies to affected areas in ukraine.
DPRO Ratings Summary
DPRO Quant Ranking